TITLE

Cystic Fibrosis and the Respiratory Therapist: A 50-Year Perspective

AUTHOR(S)
Volsko, Teresa A.
PUB. DATE
May 2009
SOURCE
Respiratory Care;May2009, Vol. 54 Issue 5, p587
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The role of the respiratory therapist in the care of patients with cystic fibrosis has expanded throughout the years. As key members of the multidisciplinary team, respiratory therapists actively participate in the medical management of patients with cystic fibrosis along the continnum of care, from acute in-patient stays to the out-patient clinic and/or home setting. Through their involvement in diagnostic testing, administering therapy, or direct bedside care, patient and caregiver education, and disease management, respiratory therapists strive to preserve lung function, maintain overall health, and improve the patient's quality of life.
ACCESSION #
40647412

 

Related Articles

  • Two Qatari siblings with cystic fibrosis and apparent mineralocorticoid excess. Zahraldin, Khalid; Janahi, Ibrahim Ahmed; Ben-Omran, Tawfeg; Alsulaiman, Reem; Hamad, Bajes; Imam, Abubakr // Annals of Thoracic Medicine;Jan-Mar2015, Vol. 10 Issue 1, p69 

    Cystic fibrosis (CF) and apparent mineralocorticoid excess (AME) syndrome are both autosomal recessive disorders that result from mutations of specific identified genes for each condition. CF is caused by defects in the Cystic fibrosis trans membrane conductance regulator (CFTR) gene which...

  • CAYSTON.  // MPR - Pediatricians' Edition;Spring/Summer2010, Vol. 21 Issue 1, pA.5 

    The article features Cayston, an inhalation solution developed for the improvement of respiratory symptoms in cystic fibrosis (CF) patients with Pseudomonas aeruginosa.

  • Cystic fibrosis. Knott, Laurence // GP: General Practitioner;5/2/2008, p26 

    The article offers information on the symptoms and treatment of cystic fibrosis (CF) in patients in Great Britain. It is an autosomal recessive disorder caused by a mutation at the CF transmembrane conductance regulator gene that affects various cellular activities. It can be present at any age...

  • Kistik Fibrozis Ä°liÅŸkili Diyabetes Mellitus Vakası. Aktaş Yılmaz, Banu; Kan, Erdal; Törüner, Füsun; Karakoç, Ayhan; Aktürk, Müjde; Kirci Oruç, Münevver; Arslan, Metin // Turkish Journal of Endocrinology & Metabolism;Dec2012, Vol. 16 Issue 4, p75 

    The incidence of cystic fibrosis-related diabetes (CFRD) has increased, since the life expectancy of cystic fibrosis (CF) patients continues to improve. CFRD increases the mortality in patients, because of the negative impacts of CFRD on pulmonary functions. Knowledge of the pathogenesis and...

  • Cystic fibrosis. Mayell, Sarah // Pulse;10/17/2012, Vol. 72 Issue 34, p30 

    The article presents a case study of an 11-year-old girl who is suffering from the cystic fibrosis since childhood. She was diagnosed with asthma and also received several courses of antibiotics in primary care but without any permanent response to the treatment. It offers information related to...

  • What did we learn from two decades of chest computed tomography in cystic fibrosis? Tiddens, Harm; Rosenow, Tim // Pediatric Radiology;Dec2014, Vol. 44 Issue 12, p1490 

    Despite our current treatment, many cystic fibrosis (CF) patients still show progressive bronchiectasis and small airways disease. Adequate detection and monitoring of progression of these structural abnormalities is needed to personalize treatment to the severity of CF lung disease of the...

  • Ivacaftor: A Novel Mutation Modulating Drug. HARIT KAPOOR; ASTHA KOOLWAL; SINGH, ANKUR // Journal of Clinical & Diagnostic Research;Nov2014, Vol. 8 Issue 11, p1 

    Cystic fibrosis (CF) is multisystemic disorder presenting in newborn period to adulthood, predominantly affecting respiratory system. It is caused by mutation in CF transmembrane conductance regulator gene. F508 is the most common mutation seen worldwide. Supportive management with...

  • Dynamic in vivo mutations within the ica operon during persistence of Staphylococcus aureus in the airways of cystic fibrosis patients. Schwartbeck, Bianca; Birtel, Johannes; Treffon, Janina; Langhanki, Lars; Mellmann, Alexander; Kale, Devika; Kahl, Janina; Hirschhausen, Nina; Neumann, Claudia; Lee, Jean C.; Götz, Friedrich; Rohde, Holger; Henke, Hanae; Küster, Peter; Peters, Georg; Kahl, Barbara C. // PLoS Pathogens;11/30/2016, Vol. 12 Issue 11, p1 

    Cystic fibrosis (CF) is associated with chronic bacterial airway infections leading to lung insufficiency and decreased life expectancy. Staphylococcus aureus is one of the most prevalent pathogens isolated from the airways of CF patients. Mucoid colony morphology has been described for...

  • Effects of Propidium Monoazide (PMA) Treatment on Mycobiome and Bacteriome Analysis of Cystic Fibrosis Airways during Exacerbation. Nguyen, Linh Do Ngoc; Deschaght, Pieter; Merlin, Sophie; Loywick, Alexandre; Audebert, Christophe; Van Daele, Sabine; Viscogliosi, Eric; Vaneechoutte, Mario; Delhaes, Laurence // PLoS ONE;12/28/2016, Vol. 11 Issue 12, p1 

    Introduction and Purpose: Propidium monoazide (PMA)-pretreatment has increasingly been applied to remove the bias from dead or damaged cell artefacts, which could impact the microbiota analysis by high-throughput sequencing. Our study aimed to determine whether a PMA-pretreatment coupled with...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics